Economy
Agreement Inked To Establish Vaccines Factory In Khazaen City Worth RO20M
Khazaen Economic City signed an agreement with Opal For Biopharmaceuticals and Business Company to establish a factory for the production of biological human vaccines to the tune of RO20mn.
The first phase of the project will be set up on a total area of 37,000 square meters.

The agreement was signed by Eng. Salim Al Thuhli, CEO of Khazaen and Sa’ad Moosa Al Junaibi, Chairman of the Board of Directors of Opal For Biopharmaceuticals and Business Company.
Al Thuhli said that this project will be the first vaccines factory in Khazaen Economic City and it targets local and international markets. The agreement, Al Thuhli added, comes as part of Khazaen’s efforts in attracting local and international investments.
-
Banking & Finance1 month agoOman Oil Marketing Company Concludes Its Annual Health, Safety, Environment, and Quality Week, Reaffirming People and Safety as a Top Priority
-
News2 months agoReport: How India & The Middle East Are Exploiting Immense Economic Synergies
-
Uncategorized2 months agoOman’s ISWK Cambridge Learners Achieve ‘Top in the World’ and National Honours in June 2025 Cambridge Series
-
News1 month agoJamal Ahmed Al Harthy Honoured as ‘Pioneer in Youth Empowerment through Education and Sport’ at CSR Summit & Awards 2025
-
Economy2 months agoPrime Minister of India Narendra Modi to Visit the Sultanate of Oman on 17-18 December
-
News2 months agoIHE Launches Eicher Pro League of Trucks & Buses in Oman
-
Economy2 months agoOman’s Net Wealth Reaches $300 Billion in 2024, Poised for Steady Growth
-
News2 months agoLiva Insurance Honored with ‘Insurer of the Year’ Award for 2025
